Career history of Robert Friesen
Former positions of Robert Friesen
Companies | Position | Start | End |
---|---|---|---|
KIADIS PHARMA N.V. | Chief Tech/Sci/R&D Officer | 2019-01-31 | 2021-07-31 |
ABLYNX | Chief Tech/Sci/R&D Officer | 2018-02-28 | 2018-12-31 |
PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 2016-05-31 | 2018-01-31 |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | 2014-04-30 | 2016-05-31 |
MORPHOSYS AG | Corporate Officer/Principal | 2005-04-30 | 2008-06-30 |
PHARMING GROUP N.V. | Chief Tech/Sci/R&D Officer | 2021-07-31 | - |
Janssen Biotherapeutics | Corporate Officer/Principal | - | - |
Training of Robert Friesen
The University of Texas at Austin | Doctorate Degree |
University of Utrecht | Graduate Degree |
Statistics
International
Netherlands | 5 |
United States | 3 |
Belgium | 3 |
Operational
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
PROQR THERAPEUTICS N.V. | Health Technology |
MORPHOSYS AG | Health Technology |
PHARMING GROUP N.V. | Health Technology |
Private companies | 4 |
---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Janssen Biotherapeutics |
- Stock Market
- Insiders
- Robert Friesen
- Experience